Sanders L M
Syntex Research, Palo Alto, California 94303.
Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):95-102. doi: 10.1007/BF03190192.
The unique requirements of peptides and proteins in designing delivery systems, and the unprecedented recent growth in the field, has driven a great deal of research into novel means of drug delivery. The search for approaches that provide formulations that are stable, bioavailable, readily manufacturable, and acceptable to the patient, has led to major advances in development of nasal and controlled release technology. The field of parenteral solution technology has also seen some new demands made of it, and what was formerly a conventional area of formulation technology has made scientific advances to meet the needs of these compounds. At the same time, strides are being made in fundamental research in areas including oral delivery, transdermal delivery, and pulsatile and 'on demand' delivery of peptides and proteins.
肽和蛋白质在设计给药系统方面的独特要求,以及该领域近年来前所未有的发展,推动了对新型给药方式的大量研究。寻找能够提供稳定、生物可利用、易于制造且患者可接受的制剂的方法,已促使鼻腔给药和控释技术取得了重大进展。肠胃外溶液技术领域也出现了一些新的需求,以前作为传统制剂技术领域的该技术也取得了科学进展以满足这些化合物的需求。与此同时,在包括口服给药、透皮给药以及肽和蛋白质的脉冲式和“按需”给药等领域的基础研究也在取得进展。